149 related articles for article (PubMed ID: 35358154)
1. Tranexamic acid is not inferior to placebo with respect to adverse events in suspected traumatic brain injury patients not in shock with a normal head computed tomography scan: A retrospective study of a randomized trial.
Harmer JW; Dewey EN; Meier EN; Rowell SE; Schreiber MA
J Trauma Acute Care Surg; 2022 Jul; 93(1):98-105. PubMed ID: 35358154
[TBL] [Abstract][Full Text] [Related]
2. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
[TBL] [Abstract][Full Text] [Related]
3. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients.
Mahmood A; Needham K; Shakur-Still H; Harris T; Jamaluddin SF; Davies D; Belli A; Mohamed FL; Leech C; Lotfi HM; Moss P; Lecky F; Hopkins P; Wong D; Boyle A; Wilson M; Darwent M; Roberts I
Emerg Med J; 2021 Apr; 38(4):270-278. PubMed ID: 33262252
[TBL] [Abstract][Full Text] [Related]
4. The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: a subgroup analysis from the prehospital TXA for TBI trial.
Rowell S; Meier EN; Gomez TH; Fleming M; Jui J; Morrison L; Bulger E; Sopko G; Weisfeldt M; Christenson J; Klotz P; McMullan J; Callum J; Sheehan K; Tibbs B; Aufderheide T; Cotton B; Gandhi R; Idris A; Frascone RJ; Ferrara M; Richmond N; Kannas D; Schlamp R; Robinson B; Dries D; Tallon J; Hendrickson A; Gamber M; Garrett J; Simonson R; McKinley WI; Schreiber M
J Trauma Acute Care Surg; 2024 Apr; ():. PubMed ID: 38685481
[TBL] [Abstract][Full Text] [Related]
5. The effects of timing of prehospital tranexamic acid on outcomes after traumatic brain injury: Subanalysis of a randomized controlled trial.
Brito AMP; Schreiber MA; El Haddi J; Meier EN; Rowell SE
J Trauma Acute Care Surg; 2023 Jan; 94(1):86-92. PubMed ID: 36138535
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
[TBL] [Abstract][Full Text] [Related]
7. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
8. Association of fibrinolysis phenotype with patient outcomes following traumatic brain injury.
Durbin S; Brito A; Johnson A; Cotton B; Rowell S; Schreiber MA
J Trauma Acute Care Surg; 2024 Mar; 96(3):482-486. PubMed ID: 37700441
[TBL] [Abstract][Full Text] [Related]
9. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials.
July J; Pranata R
BMC Neurol; 2020 Apr; 20(1):119. PubMed ID: 32252661
[TBL] [Abstract][Full Text] [Related]
11. Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial.
Nishijima DK; VanBuren J; Hewes HA; Myers SR; Stanley RM; Adelson PD; Barnhard SE; Bobinski M; Ghetti S; Holmes JF; Roberts I; Schalick WO; Tran NK; Tzimenatos LS; Michael Dean J; Kuppermann N;
Trials; 2018 Oct; 19(1):593. PubMed ID: 30376893
[TBL] [Abstract][Full Text] [Related]
12. Effect of Tranexamic Acid on Prevention of Hemorrhagic Mass Growth in Patients with Traumatic Brain Injury.
Fakharian E; Abedzadeh-Kalahroudi M; Atoof F
World Neurosurg; 2018 Jan; 109():e748-e753. PubMed ID: 29074420
[TBL] [Abstract][Full Text] [Related]
13. The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial.
Spinella PC; Bochicchio K; Thomas KA; Staudt A; Shea SM; Pusateri AE; Schuerer D; Levy JH; Cap AP; Bochicchio G
Transfusion; 2022 Aug; 62 Suppl 1():S139-S150. PubMed ID: 35765921
[TBL] [Abstract][Full Text] [Related]
14. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
CRASH-3 trial collaborators
Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
[TBL] [Abstract][Full Text] [Related]
15. EFFECTS OF TRANEXAMIC ACID ON NEUROPATHOLOGY, ELECTROENCEPHALOGRAPHY, AND CEREBRAL FIBRIN DEPOSITION IN A RAT MODEL OF POLYTRAUMA WITH CONCOMITANT PENETRATING TRAUMATIC BRAIN INJURY.
Bailey ZS; Yang X; Cardiff K; Wang P; Houchins M; Lu XC; Cao Y; Gilsdorf J; Scultetus A; Shear D
Shock; 2023 Aug; 60(2):248-254. PubMed ID: 37267223
[TBL] [Abstract][Full Text] [Related]
16. TXA does not affect levels of TBI-related biomarkers in blunt TBI with ICH: A secondary analysis of the prehospital TXA for TBI trial.
Hoefer LE; Benjamin AJ; Polcari AM; Schreiber MA; Zakrison TL; Rowell SE
J Trauma Acute Care Surg; 2024 Jan; 96(1):94-100. PubMed ID: 37807179
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of tranexamic acid administration in military trauma patients with intracranial hemorrhage: a cohort study.
Walker PF; Bozzay JD; Johnston LR; Elster EA; Rodriguez CJ; Bradley MJ
BMC Emerg Med; 2020 May; 20(1):39. PubMed ID: 32410581
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of tranexamic acid dosing strategies in traumatic major hemorrhage.
Gunn F; Stevenson R; Almuwallad A; Rossetto A; Vulliamy P; Brohi K; Davenport R
J Trauma Acute Care Surg; 2024 Feb; 96(2):216-224. PubMed ID: 37872678
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid in traumatic brain injury.
Nelson Yap KB; Albert Wong SH; Idris Z
Med J Malaysia; 2020 Nov; 75(6):660-665. PubMed ID: 33219174
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
Perel P; Prieto-Merino D; Shakur H; Roberts I
Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
